|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
7 April 2015 |
|
Main ID: |
NCT00004828 |
|
Date of registration:
|
24/02/2000 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedure
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
December 1994 |
|
Target sample size:
|
28 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00004828 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Primary Purpose: Treatment
|
|
Phase:
|
Phase 1
|
|
|
Contacts
|
|
Name:
|
Richard Mainwaring |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Children's Hospital and Health Center |
| | |
|
Key inclusion & exclusion criteria
|
- Single ventricle congenital cardiac malformation
- Must undergo modified Fontan procedure
- No concurrent medications known to interfere with thyroid metabolism including
propranolol and amiodarone
- No hepatic dysfunction
- No renal dysfunction
- No pre-existing thyroid dysfunction
Age minimum:
N/A
Age maximum:
17 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Tricuspid Atresia
|
|
Heart Defects, Congenital
|
|
Intervention(s)
|
|
Drug: liothyronine I 131
|
|
Secondary ID(s)
|
|
CHSD-585
|
|
199/13357
|
|
CHSD-FDR001195
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|